siRNA innovator ADARx (ADRX.US) launches a $350 million IPO, AbbVie acquires a 4.9% stake and invests up to $100 million
智通财经2026/09/22 07:21Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
According to Zhitong Finance APP, ADARx Pharmaceuticals is a biotechnology company in phase 3 clinical trials, developing siRNA therapies for the treatment of multiple diseases. The company announced its IPO terms on Monday.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Crypto prices
More
Bitcoin
BTC
$85,907.07
+1.26%
Ethereum
ETH
$2,738.74
+0.52%
Tether USDt
USDT
$0.9997
-0.00%
BNB
BNB
$787.28
-0.73%
XRP
XRP
$1.54
+3.46%
USDC
USDC
$0.9999
+0.00%
Solana
SOL
$117.22
+0.40%
TRON
TRX
$0.3460
+0.46%
Zcash
ZEC
$1,527.99
-1.90%
Hyperliquid
HYPE
$95.28
-0.40%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now